Herpes zoster, or shingles, is caused by reactivation of varicella zoster virus, which causes
chickenpox. There are an estimated 1 million cases in the Unites States annually, with an …

Introduction: Varicella, although a frequently benign childhood disease, nevertheless
represents a considerable health burden. WHO recommends including varicella vaccines in …

Although varicella is usually a mild and self-limited disease, complications can occur. In
1998, the World Health Organization recommended varicella vaccination for countries …

Abstract Varicella-zoster virus (VZV), an important member of the Herpesviridae family, is the
etiological agent of varicella as primary infection and zoster as recurrence. An outstanding …

Background Incremental cost-effectiveness and cost-utility analyses [health economic
evaluations (HEEs)] of vaccines are routinely considered in decision making on …

Herpes zoster (shingles) is diagnosed clinically by recognition of the distinctive, painful
vesicular rash appearing in a unilateral, dermatomal distribution. An estimated 1 million …

Introduction: Post-herpetic neuralgia (PHN) is common and treatment is often suboptimal
with less than half of patients achieving adequate 50% pain relief. As an area of unmet …

Objectives To provide a new value-based immunization approach collating the available
scientific evidence on the topic. Methods Four value pillars (personal, allocative, technical …

Background Though the disease burden of varicella in Europe has been reported
previously, the economic burden is still unknown. This study estimated the economic burden …

Background Protection against herpes zoster (HZ) induced by the live attenuated zoster
vaccine Zostavax (ZVL) wanes within 3–7 years. Revaccination may renew protection. We …